Authors: ENGERT A SCHNELL R KUPPER F REISER M ENGELHARD M WILHELM M LATHAN B BALTESENGLER S WINTERHALTER B SCHEULEN ME DEDERICHS B TESCH H WORMANN B DIEHL V

Citation: A. Engert et al., A PHASE-II STUDY WITH IDARUBICIN, IFOSFAMIDE AND VP-16 (IIVP-16) IN PATIENTS WITH REFRACTORY OR RELAPSED AGGRESSIVE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 24(5-6), 1997, pp. 513-522

Authors: SCHNELL R KUPPER F ENGELHARD M WILHELM M BALTESENGLER S WINTERHALTER B TESCH H WORMANN B DIEHL V ENGERT A

Citation: R. Schnell et al., A PHASE-II STUDY WITH IDARUBICIN, IFOSFAMIDE AND VP-16 (IIVP-16) IN PATIENTS WITH RELAPSED HIGH-GRADE NON-HODGKINS-LYMPHOMA, Blood, 86(10), 1995, pp. 3278-3278

Authors: SCHNELL R KUPPER F ENGELHARD M WILHELM M BALTESENGLER S WINTERHALTER B TESCH H WORMANN B DIEHL V ENGERT A

Citation: R. Schnell et al., IDARUBICIN, IFOSFAMIDE AND VP-16 (IIVP-16) IN PATIENTS WITH RELAPSED HIGH-GRADE NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY, Blood, 84(10), 1994, pp. 10000648-10000648